Clinical management of thromboembolic disorders in pregnancy

Early diagnosis, treatment, and appropriate prophylaxis may prevent serious maternal sequelae of thromboembolism. Objective techniques for diagnosis should be used aggressively. Heparin is the preferred anticoagulant. Although the risks and benefits of prophylaxis are currently debated, it appears m...

Full description

Saved in:
Bibliographic Details
Published inCritical care clinics Vol. 7; no. 4; p. 809
Main Authors Rutherford, S E, Phelan, J P
Format Journal Article
LanguageEnglish
Published United States 01.10.1991
Subjects
Adult
Age Factors
Anticoagulants - therapeutic use
Ethnic Groups
Female
Heparin - therapeutic use
Humans
Maternal Mortality
Pregnancy
Pregnancy Complications - diagnosis
Pregnancy Complications - mortality
Pregnancy Complications - therapy
Pulmonary Embolism - diagnosis
Pulmonary Embolism - mortality
Pulmonary Embolism - therapy
Risk Factors
Thromboembolism - diagnosis
Thromboembolism - mortality
Thromboembolism - therapy
Thrombophlebitis - diagnosis
Thrombophlebitis - mortality
Thrombophlebitis - therapy
Online AccessGet more information

Cover

More Information
Summary:Early diagnosis, treatment, and appropriate prophylaxis may prevent serious maternal sequelae of thromboembolism. Objective techniques for diagnosis should be used aggressively. Heparin is the preferred anticoagulant. Although the risks and benefits of prophylaxis are currently debated, it appears most prudent to consider subcutaneous heparin prophylaxis beginning in the first trimester.
ISSN:0749-0704
DOI:10.1016/S0749-0704(18)30282-3